Cargando…

A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation

BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made...

Descripción completa

Detalles Bibliográficos
Autores principales: Öner, Alper, Moerke, Caroline, Wolff, Anne, Kischkel, Sabine, Schmidt, Wolfram, Grabow, Niels, Ince, Hüseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392678/
https://www.ncbi.nlm.nih.gov/pubmed/32727596
http://dx.doi.org/10.1186/s40001-020-00429-y
_version_ 1783564894314954752
author Öner, Alper
Moerke, Caroline
Wolff, Anne
Kischkel, Sabine
Schmidt, Wolfram
Grabow, Niels
Ince, Hüseyin
author_facet Öner, Alper
Moerke, Caroline
Wolff, Anne
Kischkel, Sabine
Schmidt, Wolfram
Grabow, Niels
Ince, Hüseyin
author_sort Öner, Alper
collection PubMed
description BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made of bare metal stents with a polytetrafluoroethylene (PTFE) or polyurethane coating. These stents’ major limitations include higher rates of thrombus formation and restenosis. Hence, there is a still unmet need for new stents regarding their design and composition. Or, to test new covered stent designs, the rabbit iliac artery has become the best-established animal model. This study sought to present a preclinical animal approach designed to test covered stents that are utilized following vessel perforation. METHODS: The animal experiments were performed using New Zealand white rabbits, each weighting 3.5–4.5 kg. The animal models described herein relied on the three most common clinical causes for CP, such as guidewire-induced, balloon catheter bursting, and device oversizing. Moreover, the sealing capacity of covered stent grafts was assessed for each of these models by means of angiography. RESULTS: We herein report a rabbit iliac artery perforation model using three different types of vessel perforation that closely mimic the clinical setting, such as guidewire-induced, balloon catheter rupture, and device oversizing. Using the same rabbit iliac perforation model, we additionally assessed the sealing capacity of a covered stent graft for each model. CONCLUSIONS: The novel rabbit iliac artery perforation models, as described in this report, represent promising animal testing approaches. While their setting is very similar to the real-life context encountered in humans, all three models are based on an animal model that is ideally suited for evaluating the sealing capacity and performance of new medical devices for humans.
format Online
Article
Text
id pubmed-7392678
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73926782020-08-04 A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation Öner, Alper Moerke, Caroline Wolff, Anne Kischkel, Sabine Schmidt, Wolfram Grabow, Niels Ince, Hüseyin Eur J Med Res Research BACKGROUND: Percutaneous coronary intervention is among the most common therapeutic interventions in cardiology. This procedure may, however, be associated with a rare, though life-threatening complication: acute coronary perforation (CP). CP is primarily treated using covered stents, which are made of bare metal stents with a polytetrafluoroethylene (PTFE) or polyurethane coating. These stents’ major limitations include higher rates of thrombus formation and restenosis. Hence, there is a still unmet need for new stents regarding their design and composition. Or, to test new covered stent designs, the rabbit iliac artery has become the best-established animal model. This study sought to present a preclinical animal approach designed to test covered stents that are utilized following vessel perforation. METHODS: The animal experiments were performed using New Zealand white rabbits, each weighting 3.5–4.5 kg. The animal models described herein relied on the three most common clinical causes for CP, such as guidewire-induced, balloon catheter bursting, and device oversizing. Moreover, the sealing capacity of covered stent grafts was assessed for each of these models by means of angiography. RESULTS: We herein report a rabbit iliac artery perforation model using three different types of vessel perforation that closely mimic the clinical setting, such as guidewire-induced, balloon catheter rupture, and device oversizing. Using the same rabbit iliac perforation model, we additionally assessed the sealing capacity of a covered stent graft for each model. CONCLUSIONS: The novel rabbit iliac artery perforation models, as described in this report, represent promising animal testing approaches. While their setting is very similar to the real-life context encountered in humans, all three models are based on an animal model that is ideally suited for evaluating the sealing capacity and performance of new medical devices for humans. BioMed Central 2020-07-29 /pmc/articles/PMC7392678/ /pubmed/32727596 http://dx.doi.org/10.1186/s40001-020-00429-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Öner, Alper
Moerke, Caroline
Wolff, Anne
Kischkel, Sabine
Schmidt, Wolfram
Grabow, Niels
Ince, Hüseyin
A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title_full A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title_fullStr A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title_full_unstemmed A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title_short A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
title_sort preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392678/
https://www.ncbi.nlm.nih.gov/pubmed/32727596
http://dx.doi.org/10.1186/s40001-020-00429-y
work_keys_str_mv AT oneralper apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT moerkecaroline apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT wolffanne apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT kischkelsabine apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT schmidtwolfram apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT grabowniels apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT incehuseyin apreclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT oneralper preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT moerkecaroline preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT wolffanne preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT kischkelsabine preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT schmidtwolfram preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT grabowniels preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation
AT incehuseyin preclinicalanimalmodelforevaluatingthesealingcapacityofcoveredstentgraftsinacutevesselperforation